Article Contents ::
- 1 The Brand Name 5-FLUOROURACIL Has Generic Salt :: 5-Fluorouracil
- 2 5-FLUOROURACIL Is From Company Vhb Priced :: Rs. 69
- 3 5-FLUOROURACIL have 5-Fluorouracil is comes under Sub class #N/A of Main Class #N/A
- 4 Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name 5-FLUOROURACIL Has Generic Salt :: 5-Fluorouracil
5-FLUOROURACIL Is From Company Vhb Priced :: Rs. 69
5-FLUOROURACIL have 5-Fluorouracil is comes under Sub class #N/A of Main Class #N/A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| 5-Fluorouracil | INJ | Rs. 69 | AMP. |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / AMP. |
| 5-FLUOROURACIL | Vhb | 250MG/5ML | AMP. | Rs. 69 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From Vhb :: 5-FLUOROURACIL | 5-Fluorouracil | #N/A | #N/A |
Indications for Drugs ::
Palliation of malignant neoplasms, Superficial basal cell carcinoma, Oesophageal carcinoma
Drug Dose ::
Adult: IV Palliation of malignant neoplasms 12 mg/kg/day (max: 0.8-1g/day) for 3-4 days, if no toxicity occurs, may be followed after 1 day w/ 6 mg/kg on alternate days for another 3-4 doses. May repeat course 4-6 wk later or maintenance doses of 5-15 mg/kg (max: 1 g) may be given wkly. As an infusion: 15 mg/kg/day (max: 1 g/day), continue until toxicity occurs or a total of 12-15 g is given. May repeat course 4-6 wk later. Intra-arterial Palliation of malignant neoplasms 5-7.5 mg/kg/day as continuous infusion (regional perfusion). Child: Safety & efficacy not established.
Contraindication ::
Topical application on mucous membranes, exposure to sunlight, hypersensitivity. Depressed bone marrow function, poor nutritional status, potentially serious infections. Pregnancy and lactation.
Drug Precautions ::
Regular monitoring of blood counts. History of heart disease, hepatic or renal insufficiency, weak or malnourished patients, patients who with history of high-dose pelvic radiation or use of alkylating agents. Patients with widespread metastases to the bone marrow.
Drug Side Effects ::
Leucopenia, thrombocytopaenia, stomatitis, GI ulceration, bleeding and diarrhoea, haemorrhage from any site (stop treatment). Nausea, vomiting, rashes, hyperpigmentation, alopecia. Topical: Local inflammatory and photosensitivity reactions. Dermatitis and erythema multiforme (rare). Potentially Fatal: Central neurotoxicity, myocardial ischaemia.
Pregnancy category ::
4
Drug Mode of Action ::
Fluorouracil interferes with DNA synthesis by blocking the conversion of deoxyuridylic acid to thymidylic acid. It also interferes with RNA synthesis. This results in an unbalanced growth of the cells. Fluorouracil exerts greater effect on rapidly growing cells as they take up the drug at a faster rate.
Drug Interactions ::
May increase warfarin effects. May reduce response to vaccines; possibility of generalized infection with live vaccines. Action may be modified by allopurinol. Leucovorin calcium may enhance the toxicity of fluorouracil.
